 INFU surprised investors by pre-releasing disappointing FY21 results, leading to a 25 selloff in shares the same day. Nothing about INFUs long-term trajectory changed as the 4Q21 miss is understandable and temporary, relating to Omicron disruptions and a delay in contract execution with one partner. 